FRANKLIN LAKES, N.J., Dec. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced the expansion of its respiratory and sexually ...
BD announced the expansion of its respiratory and sexually transmitted infection diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation certification of two VIASURE ...
ZARAGOZA, Spain and FRANKLIN LAKES, N.J., Oct. 21, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics portfolio in Europe. This follows the ...
The U.S. Food and Drug Administration (FDA) alerted clinical laboratory staff and health care providers of an increased risk of a false-positive result with BD SARS-CoV-2 Reagents for the BD Max ...
AMSTERDAM, Sept. 29, 2020/PRNewswire/ -- BioGX BV, the European subsidiary of Birmingham, Alabama based BioGX, announced availability of a CE-IVD marked test for simultaneous detection of SARS-CoV-2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback